These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [A case of delayed colonic perforation after metallic stent placement for advanced descending colon cancer during bevacizumab-based chemotherapy]. Tanaka I; Hisai H; Miyazaki E; Ono M; Maeda Y; Sato M; Kawasaki R; Gyobu H; Nakajima S; Yamada S; Muramatsu H Gan To Kagaku Ryoho; 2011 Nov; 38(12):2319-21. PubMed ID: 22202368 [TBL] [Abstract][Full Text] [Related]
5. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy. August DA; Serrano D; Poplin E J Surg Oncol; 2008 Feb; 97(2):180-5. PubMed ID: 18095268 [TBL] [Abstract][Full Text] [Related]
6. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure. de Melo JV; Vieira de Melo MS; Abad MH Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793 [TBL] [Abstract][Full Text] [Related]
12. Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer. Mutlu H; Berk V; Karaca H; Erden A; Aslan T; Akca Z Clin Appl Thromb Hemost; 2012 Sep; 18(5):546-8. PubMed ID: 22203035 [TBL] [Abstract][Full Text] [Related]
13. [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer]. Kuwabara H; Baba H; Wakabayashi M; Nakamura H; Sanada T; Baba H; Nakajima K; Goseki N Gan To Kagaku Ryoho; 2011 Nov; 38(12):2250-2. PubMed ID: 22202345 [TBL] [Abstract][Full Text] [Related]
14. Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer. Stevenson JP; Langer CJ; Somer RA; Evans TL; Rajagopalan K; Krieger K; Jacobs-Small M; Dyanick N; Milcarek B; Coakley S; Walker S; Eaby-Sandy B; Hageboutros A Cancer; 2012 Nov; 118(22):5580-7. PubMed ID: 22544579 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the long-term pharmacokinetics of bevacizumab following last dose in patients with resected stage II and III carcinoma of the colon. Li J; Gupta M; Jin D; Xin Y; Visich J; Allison DE Cancer Chemother Pharmacol; 2013 Mar; 71(3):575-80. PubMed ID: 23228985 [TBL] [Abstract][Full Text] [Related]
17. Why do targeted agents not work in the adjuvant setting in colon cancer? Oyan B Expert Rev Anticancer Ther; 2012 Oct; 12(10):1337-45. PubMed ID: 23176621 [TBL] [Abstract][Full Text] [Related]
18. Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX. Leite D; Kater FR Anticancer Drugs; 2011 Jun; 22 Suppl 2():S1-7. PubMed ID: 21768791 [TBL] [Abstract][Full Text] [Related]
19. Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade. Esfahani K; Miller WH N Engl J Med; 2017 May; 376(20):1989-91. PubMed ID: 28514612 [No Abstract] [Full Text] [Related]
20. Vulvar mucinous adenocarcinoma associated with Crohn's disease: report of two cases. Matsuo K; Chi DS; Eno ML; Im DD; Rosenshein NB Gynecol Obstet Invest; 2009; 68(4):276-8. PubMed ID: 19828998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]